[Recommendation of the Polish Neurologic Society and the Polish Neurosurgical Society regarding stroke prevention and therapy].
D000959:Antihypertensive Agents / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000517:prevention & control*; D008019:Life Style; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011044:Poland; D011322:Primary Prevention / Q000379:methods; D011785:Quality Assurance, Health Care; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control*; D000071939:Stroke Rehabilitation; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D018696:Neuroprotective Agents; D010959:Tissue Plasminogen Activator